Astrazeneca (AZN) EPS (Basic) (2009 - 2026)
Astrazeneca's EPS (Basic) came in at $2.01 for Q3 2026, up 23.1% from $1.63 a year earlier and up 24.3% from the prior quarter.
Powered by 
Analysis
Astrazeneca (AZN) EPS (Basic) (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Astrazeneca reported EPS (Basic) of $7.12, up 17.4% year-over-year; for FY2025, it came in at $6.60, up 45.3% from FY2024.
- EPS (Basic) has increased in each of the last three years, with a five-year compound annual growth rate of 22.0% (FY2020 to FY2025).
- Going back by year, EPS (Basic) was $4.54 in FY2024 (+18.1%), $3.84 in FY2023 (+81.0%), $2.12 in FY2022 and $0.08 in FY2021 (-96.8%).
- The Q3 2026 figure represents the highest quarterly EPS (Basic) since Q4 2014.
- Year-over-year, EPS (Basic) has increased for 12 consecutive quarters, with growth averaging 35.0% over the last eight quarters.
- The fastest year-over-year change in EPS (Basic) over five years came in Q2 2023 (growth of 363.1%), and the weakest in Q1 2022 (a decline of 77.1%).
- Business Quant data shows AZN's EPS (Basic) at $1.62 (Q2 2026), $1.99 (Q1 2026) and $1.50 (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 7.23 |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 0.09 |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 2.38 |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 2.05 |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 2.01 |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 7.14 |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 1.96 |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 0.57 |
| 10 | Vertex Pharmaceuticals | 136.55 Bn | 104.28 Bn | 2.91 Bn | 2.58 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 2.01 |
| Jun 30, 2026 | 1.62 |
| Mar 31, 2026 | 1.99 |
| Dec 31, 2025 | 1.50 |
| Sep 30, 2025 | 1.63 |
| Jun 30, 2025 | 1.58 |
| Mar 31, 2025 | 1.88 |
| Dec 31, 2024 | 0.97 |
| Sep 30, 2024 | 0.92 |
| Jun 30, 2024 | 1.24 |
| Mar 31, 2024 | 1.41 |
| Dec 31, 2023 | 0.62 |
| Sep 30, 2023 | 0.89 |
| Jun 30, 2023 | 1.18 |
| Mar 31, 2023 | 1.16 |
| Dec 31, 2022 | 0.58 |
| Sep 30, 2022 | 1.16 |
| Jun 30, 2022 | 0.25 |
| Mar 31, 2022 | 0.27 |
| Dec 31, 2021 | -0.24 |
API Access
Astrazeneca EPS (Basic) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=eps-basic&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "eps-basic", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=eps-basic&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();